ATE231399T1 - Verwendung eines kationischen polymer zur herstellung von nukleinsäure-komplexe und verwandte zusammensetzungen - Google Patents

Verwendung eines kationischen polymer zur herstellung von nukleinsäure-komplexe und verwandte zusammensetzungen

Info

Publication number
ATE231399T1
ATE231399T1 AT98402142T AT98402142T ATE231399T1 AT E231399 T1 ATE231399 T1 AT E231399T1 AT 98402142 T AT98402142 T AT 98402142T AT 98402142 T AT98402142 T AT 98402142T AT E231399 T1 ATE231399 T1 AT E231399T1
Authority
AT
Austria
Prior art keywords
nucleic acid
cationic polymer
acid complexes
related compositions
producing nucleic
Prior art date
Application number
AT98402142T
Other languages
English (en)
Inventor
Hanno V J Kolbe
Otmane Boussif
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE231399T1 publication Critical patent/ATE231399T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT98402142T 1998-08-28 1998-08-28 Verwendung eines kationischen polymer zur herstellung von nukleinsäure-komplexe und verwandte zusammensetzungen ATE231399T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98402142A EP0987029B1 (de) 1998-08-28 1998-08-28 Verwendung eines kationischen Polymer zur Herstellung von Nukleinsäure-Komplexe und verwandte Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE231399T1 true ATE231399T1 (de) 2003-02-15

Family

ID=8235477

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98402142T ATE231399T1 (de) 1998-08-28 1998-08-28 Verwendung eines kationischen polymer zur herstellung von nukleinsäure-komplexe und verwandte zusammensetzungen

Country Status (8)

Country Link
EP (1) EP0987029B1 (de)
JP (1) JP2000135082A (de)
AT (1) ATE231399T1 (de)
AU (1) AU750696B2 (de)
CA (1) CA2281442A1 (de)
DE (1) DE69810925T2 (de)
DK (1) DK0987029T3 (de)
ES (1) ES2191269T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048819A1 (en) * 2000-10-09 2004-03-11 Joachim Simon Complexes for transferring nucleic acids into cells
JP2004521109A (ja) * 2001-01-17 2004-07-15 ザイコス インク． 核酸輸送用製剤
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
EP3235513A1 (de) * 2016-04-18 2017-10-25 Université de Liège Verbesserungen an oder im zusammenhang mit organischem material

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2110543T3 (es) * 1992-07-22 1998-02-16 Hoechst Ag Derivados de poli(vinil-aminas) que tienen centros hidrofilos, procedimiento para su preparacion asi como la utilizacion de los compuestos como medicamentos, vehiculos de sustancias activas e ingredientes auxiliares para alimentos.
US5629184A (en) * 1995-01-25 1997-05-13 Amgen Inc. Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
FR2744453B1 (fr) * 1996-02-05 1998-07-10 Transgene Sa Composes lipopolyamines, compositions pharmaceutiques en comprenant, vecteurs de transfert d'acide nucleique et procede de preparation

Also Published As

Publication number Publication date
DE69810925T2 (de) 2004-01-08
JP2000135082A (ja) 2000-05-16
AU4472799A (en) 2000-03-16
AU750696B2 (en) 2002-07-25
EP0987029A1 (de) 2000-03-22
DK0987029T3 (da) 2003-03-31
CA2281442A1 (en) 2000-02-28
DE69810925D1 (de) 2003-02-27
ES2191269T3 (es) 2003-09-01
EP0987029B1 (de) 2003-01-22

Similar Documents

Publication Publication Date Title
HUP0002543A1 (hu) Sziloxánalapú poliamidok, ilyen poliamidokat sűrítőszerként tartalmazó alapkompozíciók és kozmetikai készítmények, valamint eljárás egyes szilikon-poliamidok előállítására
ATE260941T1 (de) Funktionalisierte polyallylamine und verfahren zur herstellung davon
DE3855283D1 (de) Polymerisationsverfahren und Polymerisationskatalysator
HK1080880A1 (zh) 氟聚合物組合物
DE69026980D1 (de) Schwefel enthaltende kondensierte Pyrimidinderivate, ihre Herstellung und Verwendung
ATE176237T1 (de) Sphingoglycolipid und verwendung davon
ATE71090T1 (de) Heterocyclische verbindungen und deren herstellung und verwendung.
DE60306781D1 (de) Naturstoffe und deren derivate zur prävention und behandlung von herzkreislauf-, leber- und nierenerkrankungen und für kosmetische anwendungen
ATE202702T1 (de) Verwendung von oestrogenagonisten und - antagonisten zur herstellung eines medikaments zur behandlung von atherosklerose, unabhängig von lipidsenkung
FR2812551B1 (fr) Forme pharmaceutique comprenant un materiau support a base de methylidene malonate et un facteur de regulation cellulaire
DE59400332D1 (de) Vernetzbare Siloxan-Zusammensetzungen und deren Verwendung zur Herstellung von klebrige Stoffe abweisenden Überzügen
ATE432956T1 (de) Blockcopolymere und verwendung davon
ATE136891T1 (de) Salze von triazinderivaten mit oxygenierter phosphorsäure und ihre verwendung in selbstlöschenden polymerzusammensetzungen
HUP0102599A2 (hu) Artemizinin-származékok, eljárás a vegyületek előállítására, és a vegyületeket tartalmazó gyógyszerészeti készítmények
ATE231399T1 (de) Verwendung eines kationischen polymer zur herstellung von nukleinsäure-komplexe und verwandte zusammensetzungen
ATE140019T1 (de) Polysiloxan-stabilisatoren mit sterisch gehinderten phenolgruppen und oxamidgruppen
DE3863883D1 (de) Haertungskomponente und deren verwendung.
EP1443042A4 (de) Hybrid-oniumsalz
DE69923860D1 (de) Flammhemmende harzzusammensetzungen, enthaltend phosphoramide, und herstellungsmethode
KR910015537A (ko) 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물
DE60003671D1 (de) Halo-derivate von 9-deoxo-9a-aza-9a-homerythromycin a
DE69501705T2 (de) Verfahren zur Herstellung von optisch aktiven Piperazinderivaten und Zwischenprodukten für ihre Herstellung
ATE177750T1 (de) Phosphonig-, phosphinig- oder phosphonsäure derivate als stabilisatoren für organische materialen
NO923331D0 (no) N-substituerte aminometandifosfonsyrer
ATE232222T1 (de) Verträglich machendes agens und methode zur herstellung desselben

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0987029

Country of ref document: EP

REN Ceased due to non-payment of the annual fee